Substances Search Engine Updates

On September 25, 2026, the Government of Canada notified stakeholders of an update to the Substance Search Tool. This update added two new lists: Conclusions of the Assessment of […]

On September 25, 2026, the Government of Canada notified stakeholders of an update to the Substance Search Tool. This update added two new lists: Conclusions of the Assessment of […]

The Government of Canada has shared its Risk Assessment Publications Plan for October to December 2026, providing stakeholders with advance notice of anticipated Chemicals Management Plan (CMP) publications. Note […]

On October 2, 2026, Health Canada and Environment and Climate Change Canada published a consultation on the development of regulations establishing criteria for determining whether substances are carcinogenic, mutagenic […]

As noted in our August Member Alert, the Government of Canada is continuing its work to add eligible substances from the Revised In Commerce List (R-ICL) to the Domestic […]

The Natural & Non-prescription Health Products Directorate made updates and revisions to monographs on September 25, 2026. Notable changes include various minor revisions to Oral Health and Medicated Skin […]

The Natural and Non-prescription Health Products Directorate (NNHPD) has launched a new email notification service to inform industry stakeholders whenever updates are published to the Natural Health Products […]

PRODUCT APPLICATIONS: Class I Applications: Currently meeting service standards. Class II Applications (meeting Workload Management eligibility criteria): There are approximately 1050 prioritized files in Class II (this includes new […]

BACKGROUND A few members have recently approached CA Canada regarding a possible escalation of enforcement attention on synthetic waxes (or waxes) as Microbeads. As members are aware, […]
On August 21, 2026, the Scientific Advisory Group on Chemicals Safety (SAG-CS) published a number of opinions on several cosmetic ingredients. Triclocarban The Scientific Advisory Group on Chemicals Safety […]

The U.S. Food and Drug Administration (FDA) has issued a final administrative order, officially removing aminobenzoic acid (PABA) and trolamine salicylate from the list of approved active ingredients in […]